Rigel Pharmaceuticals RIGL reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Rigel Pharmaceuticals beat estimated earnings by 33.33%, reporting an EPS of $-0.08 versus an estimate of $-0.12.
Revenue was up $3.55 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.02 which was followed by a 6.45% increase in the share price the next day.
Here's a look at Rigel Pharmaceuticals's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | -0.14 | -0.13 | -0.10 | -0.11 |
EPS Actual | -0.16 | -0.11 | -0.12 | -0.08 |
Revenue Estimate | 17.54M | 21.90M | 23.56M | 20.37M |
Revenue Actual | 16.73M | 20.41M | 21.54M | 26.27M |
To track all earnings releases for Rigel Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.